The successful candidate will break news on an industry that has benefited tremendously, both in terms of profit and influence, from developing vaccines and treatments critical to alleviating the COVID pandemic. At the same time, the industry is fending off efforts to curb the rising costs of prescription medicines and faces increasing pushback from national regulators over drug approvals.
This reporter would break news on how companies like Pfizer and Moderna will spend the billions of dollars earned off the pandemic, including a new push for acquisitions after a long hiatus. The candidate will report on how the pharma industry is exercising its enhanced leverage with governments, in Washington and abroad, seeking to sway major policy decisions on how drugs are approved and priced, from insulin to Alzheimer’s treatments.
The reporter would be deeply sourced among pharmaceutical and biotech executives, U.S. government health officials and industry investors. The preferred location for the role is New York.
About the Role
As our U.S. Pharmaceutical Industry Reporter, you will:
About You
To be our U.S. Pharmaceutical Industry Reporter, you will likely have:
(Internal candidates: Please note this position is incorrectly listed as being in the EIC job family).
Please note, the deadline for applications is Sunday 5th June 2022.
To apply, go here.
The Pacific Business News, an American City Business Journals publication, has hired Janis Magin Meierdiercks as…
Sadia Nowshin, a reporter at European startup news site Sifted, is leaving to join literary…
Variety has promoted Ethan Shanfeld to TV reporter. William Earl of Variety writes, "Shanfeld joins the entertainment…
Kasia Klimasinska is the new team leader for DC breaking news at Bloomberg News. She…
Paul Smalera has organized a gathering of James Ledbetter's friends and colleagues—open to all…
Real estate news service CoStar News has hired Rachel Scheier to cover the San Francisco commercial market.…